Evaluating the role of individualised homoeopathic remedy selected from the compiled repertory in case of pathological leucorrhoea : An open label prospective Quasi experimental study
Trial Snapshot
- Phase
- Phase 3
- Status
- Not yet recruiting
- Sponsor
- Enrollment
- 50
- Locations
- 1
- Primary Endpoint
- 2.To evaluate change in the quality of life in Leucorrhea patients by homoeopathic medicines.
Study Overview
Brief Summary
This study is the Non Randomized, single blind open label prospective Quasi experimental study to see the results of the complied repertory in the treatment of pathological leucorrhea using Vaginal assessment form and ORIDL score. The duration of treatment will be 3 months and will be done on 50 patients at Bharati Vidyapeeth Medical Foundation Homoeopathic Hospital, peripheral O.P.D,various rural and urban camp series,O.P.D,I.P.D. The primary outcome will be assessed using the follow up taken for 3 months to see the effectiveness of homoeopathic medicines in the treatment of Pathological Leucorrhea. To see whether compiled repertory is useful in clinical prescribing of final similimum. The secondary outcome will measure the improvement in symptoms of patients using vaginal assessment form and ORIDL score at day 1 and 3rd month.
Study Design
- Study Type
- Interventional
- Allocation
- Not Applicable
- Masking
- Not Applicable
Eligibility Criteria
- Ages
- 18.00 Year(s) to 65.00 Year(s) (—)
- Sex
- Female
Inclusion Criteria
- •1 Patient attending OPD who is suffering from Leucorrhoea which is defined will be included for the study.
- •2 Married Women irrespective of their religious and socio-economic status.
- •3 Patient who are willing to take part in the study.
Exclusion Criteria
- •1 Patient taking oral contraceptives pills.
- •2 Patient having defined life-threatening pathology in genital tract.
- •3 Patient with Malignancy cases.
- •4 Pregnant women and lactating mothers.
Outcomes
Primary Outcomes
2.To evaluate change in the quality of life in Leucorrhea patients by homoeopathic medicines.
Time Frame: the follow ups taken at every 15 days will be assessed for duration of 3 months using vaginal assessment form and ORIDL score at the beginning and end of treatment i.e. after 12 weeks and most prescribed homoeopathic medicine using complied repertory will be evaluated.
3.To determine the utility of compiled repertory for individualized homoeopathic treatment of pathological Leucorrhea.
Time Frame: the follow ups taken at every 15 days will be assessed for duration of 3 months using vaginal assessment form and ORIDL score at the beginning and end of treatment i.e. after 12 weeks and most prescribed homoeopathic medicine using complied repertory will be evaluated.
1.To enlist the most frequently prescribed medicine for pathological Leucorrhea with their indication.
Time Frame: the follow ups taken at every 15 days will be assessed for duration of 3 months using vaginal assessment form and ORIDL score at the beginning and end of treatment i.e. after 12 weeks and most prescribed homoeopathic medicine using complied repertory will be evaluated.
Secondary Outcomes
- To compile a Leucorrhea based repertory from all well-known established repertories.(To evaluate change in the quality of life in Leucorrhea patients by homoeopathic medicines.)